REED JOHN C

JNJ

REED JOHN C serves as EVP, Innovative Medicine, R&D at Johnson & Johnson (JNJ). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$20.70M

Net Position

Net Seller

$20.70M

Companies Traded

JNJ

Active Period

Feb 2025 – Feb 2026

4 total trades

Most Recent

Sell JNJ

Feb 15, 2026 · $13.33M

REED JOHN C's Insider Trading at Johnson & Johnson (JNJ)

Buys

0 · $0.00

Sells

4 · $20.70M

Total Shares Bought

Total Shares Sold

96,087

JNJ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 15, 2026	Sell	54,844	$243.01	$13.33M
Oct 20, 2025	Sell	21,721	$192.71	$4.19M
Jul 18, 2025	Sell	19,137	$163.55	$3.13M
Feb 18, 2025	Sell	385	$156.15	$60.1K

Related Insiders

Robert J Decker

VP Corporate Controller

JNJSell · Mar 3, 2026

Timothy Schmid

EVP, WW Chair, MedTech

JNJSell · Feb 20, 2026

Kathryn E Wengel

EVP, Chief TO and Risk Officer

JNJSell · Feb 18, 2026

Kristen Mulholland

EVP, Chief HR Officer

JNJSell · Feb 13, 2026

Joseph J Wolk

Exec VP, CFO

JNJSell · Feb 13, 2026

Joaquin Duato

director, officer: CEO and Chairman of the Board

JNJSell · Feb 13, 2026

Elizabeth Forminard

Executive VP, General Counsel

JNJSell · Feb 13, 2026

Jennifer L Taubert

EVP, WWC. Innovative Medicine

JNJSell · Feb 13, 2026

Explore More Insider Trading Data

JNJ Insider Trading Activity

View all insider trades at Johnson & Johnson

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity